Literature DB >> 12040284

Role of radiotherapy for primary orbital lymphoma.

Sang-Wook Lee1, Chang Ok Suh, Gwi Eon Kim, Woo Ick Yang, Sang Yeul Lee, Jee Sook Hahn, Joon Oh Park.   

Abstract

To define the role of radiation therapy of primary orbital lymphoma, a retrospective analysis was undertaken for 18 patients with primary orbital lymphoma who were treated with curative radiotherapy between 1984 and 1995. The histology was found to be low grade lymphoma in 11 patients, intermediate grade in 7. All patients were of Ann Arbor stage IE, but bilateral involvement of the orbit was observed in 3 patients (16.6%). Anatomical subsites involved were the retrobulbar, eyelid, and conjunctiva in eight, five, and four patients, respectively. The median radiation dose was 30 Gy ranging from 20 Gy to 50 Gy. Twelve of 18 patients received a radiation dose of 30 Gy or less. To properly protect the lens during irradiation, the contact lens blocks were used for nine patients with conjunctival and eyelid tumor or the hanging eye bar blocks were applied for eight patients with retrobulbar tumor. Chemotherapy was given for seven patients with intermediate-grade malignant lymphoma. Two patients had been treated by surgery before referral.

Entities:  

Mesh:

Year:  2002        PMID: 12040284     DOI: 10.1097/00000421-200206000-00011

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  7 in total

1.  Intraorbital lymphomas: neurosurgical experiences and management strategies.

Authors:  Nedal Hejazi
Journal:  Neurosurg Rev       Date:  2006-01-06       Impact factor: 3.042

2.  Electron therapy for orbital and periorbital lesions using customized lead eye shields.

Authors:  Keiji Hayashi; Kunito Hatsuno; Ryo-ichi Yoshimura; Toshiaki Iida; Fumio Ayukawa; Kazuma Toda; Hisashi Taniguchi; Hitoshi Shibuya
Journal:  Ophthalmologica       Date:  2008-11-26       Impact factor: 3.250

3.  Long-Term Clinical Outcomes in Treatment-Naïve Patients With Orbital Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Single-Center Study.

Authors:  Gi-June Min; Sung Eun Kim; Tong Yoon Kim; Young-Woo Jeon; Joo Hyun O; Byung-Ock Choi; Gyeongsin Park; Suk-Woo Yang; Seok-Goo Cho
Journal:  Front Oncol       Date:  2022-05-06       Impact factor: 5.738

4.  Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients.

Authors:  Su-Ho Lim; Minkyu Kang; Junhyuk Son
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

5.  Atypical presentation and diagnostic pitfalls: a case of rapidly progressive bilateral proptosis in a child aged 18 months.

Authors:  Subrahmanya K Bhat; Sachet P Shrestha; Rimli Barthakur; Maya Natarajan
Journal:  Indian J Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 1.848

6.  Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II study.

Authors:  Sung-Yong Kim; Suk-Woo Yang; Won-Sik Lee; Jae Wook Yang; Sung Yong Oh; Hee Bae Ahn; Deok-Hwan Yang; Seong Kyu Park; Jee Ho Chang; Hyo Jung Kim; Min Joung Lee; Seok-Goo Cho
Journal:  Oncotarget       Date:  2017-08-02

7.  Relapse in patients with limited-stage ocular adnexal lymphoma treated by chemoimmunotherapy: Extended follow-up of a phase 2 study.

Authors:  Sung-Yong Kim; Won-Sik Lee; Sung Yong Oh; Deok-Hwan Yang; Hyo Jung Kim; Seong Kyu Park; Jae Wook Yang; Suk-Woo Yang; Seok-Goo Cho
Journal:  Cancer Med       Date:  2022-03-11       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.